<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">88204</article-id><article-id pub-id-type="doi">10.7554/eLife.88204</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Transmembrane protein CD69 acts as an S1PR1 agonist</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-305550"><name><surname>Chen</surname><given-names>Hongwen</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1065-9808</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-305551"><name><surname>Qin</surname><given-names>Yu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-305552"><name><surname>Chou</surname><given-names>Marissa</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-260515"><name><surname>Cyster</surname><given-names>Jason G</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-122054"><name><surname>Li</surname><given-names>Xiaochun</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0177-0803</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Molecular Genetics</institution>, <institution>The University of Texas Southwestern Medical Center</institution>, <addr-line><named-content content-type="city">Dallas</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Microbiology and Immunology</institution>, <institution>University of California, San Francisco</institution>, <addr-line><named-content content-type="city">San Francisco</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Microbiology and Immunology</institution>, <institution>Howard Hughes Medical Institute, University of California, San Francisco</institution>, <addr-line><named-content content-type="city">San Francisco</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-42610"><name><surname>Sohn</surname><given-names>Jungsan</given-names></name><role>Reviewing editor</role><aff><institution>Johns Hopkins University School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>jason.cyster@ucsf.edu</email> (JC);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>xiaochun.li@utsouthwestern.edu</email> (XL);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>11</day><month>04</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e88204</elocation-id><history><date date-type="received"><day>04</day><month>04</month><year>2023</year></date><date date-type="accepted"><day>09</day><month>04</month><year>2023</year></date></history><permissions><copyright-statement>Â© 2023, Chen et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Chen et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-88204-v1.pdf"/><abstract><p>The activation of Sphingosine-1-phosphate receptor 1 (S1PR1) by S1P promotes lymphocyte egress from lymphoid organs, a process critical for immune surveillance and T cell effector activity. Multiple drugs that inhibit S1PR1 function are in use clinically for the treatment of autoimmune diseases. Cluster of Differentiation 69 (CD69) is an endogenous negative regulator of lymphocyte egress that interacts with S1PR1 in <italic>cis</italic> to facilitate internalization and degradation of the receptor. The mechanism by which CD69 causes S1PR1 internalization has been unclear. Moreover, although there are numerous class A GPCR structures determined with different small molecule agonists bound, it remains unknown whether a transmembrane protein per se can act as a class A GPCR agonist. Here, we present the cryo-EM structure of CD69-bound S1PR1 coupled to the heterotrimeric G<sub>i</sub> complex. The transmembrane helix (TM) of one protomer of CD69 homodimer contacts the S1PR1-TM4. This interaction allosterically induces the movement of S1PR1-TMs 5-6, directly activating the receptor to engage the heterotrimeric G<sub>i</sub>. Mutations in key residues at the interface affect the interactions between CD69 and S1PR1, as well as reduce the receptor internalization. Thus, our structural findings along with functional analyses demonstrate that CD69 acts in <italic>cis</italic> as a protein agonist of S1PR1, thereby promoting G<sub>i</sub>-dependent S1PR1 internalization, loss of S1P gradient sensing, and inhibition of lymphocyte egress.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>P01 HL160487</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Xiaochun</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 GM135343</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Xiaochun</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000928</institution-id><institution>Welch Foundation</institution></institution-wrap></funding-source><award-id>I-1957</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Xiaochun</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>The 3D cryo-EM density maps have been deposited in the Electron Microscopy Data Bank under the accession number EMD-29861.  Atomic coordinates for the atomic model have been deposited in the Protein Data Bank under the accession number 8G94.  All other data needed to evaluate the conclusions in the paper are present in the paper and/or the supplementary materials.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Li X</collab><collab>et al</collab></person-group><year iso-8601-date="2023">2023</year><source>Transmembrane protein CD69 acts as an S1PR1 agonist</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/8G94">https://www.rcsb.org/structure/8G94</ext-link><comment>PDB, 8G94</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Li X</collab><collab>et al</collab></person-group><year iso-8601-date="2023">2023</year><source>Transmembrane protein CD69 acts as an S1PR1 agonist</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/emdb/EMD-29861">https://www.ebi.ac.uk/emdb/EMD-29861</ext-link><comment>EMBD, EMD-29861</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-88204-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>